Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam

Human Vaccines & Immunotherapeutics
Olivier Le Polain de WarouxS Flasche

Abstract

Although catch-up campaigns (CCs) at the introduction of pneumococcal conjugate vaccines (PCVs) may accelerate their impact, supply constraints may limit their benefit if the need for additional PCV doses results in introduction delay. We studied the impact of PCV13 introduction with and without CC in Nha Trang, Vietnam - a country that has not yet introduced PCV - through a dynamic transmission model. We modelled the impact on carriage and invasive pneumococcal disease (IPD) of routine vaccination (RV) only and that of RV with CCs targeting <1y olds (CC1), <2y olds (CC2) and <5y olds (CC5). The model was fitted to nasopharyngeal carriage data, and post-PCV predictions were based on best estimates of parameters governing post-PCV dynamics. With RV only, elimination in carriage of vaccine-type (VT) serotypes is predicted to occur across all age groups within 10 years after introduction, with near-complete replacement by non-VT. Most of the benefit of CCs is predicted to occur within the first 3 years with the highest impact at one year, when IPD incidence is predicted to be 11% (95%CrI 9 - 14%) lower than RV with CC1, 25% (21 - 30 %) lower with CC2 and 38% (32 - 46%) lower with CC5. However, CCs would only prevent more cases of ...Continue Reading

References

Feb 15, 2003·The Pediatric Infectious Disease Journal·Katherine L O'BrienUNKNOWN World Health Organization Pneumococcal Vaccine Trials Carriage Working Group
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Faryal GhaffarGeorge H McCracken
Sep 14, 2006·American Journal of Epidemiology·Jacco WallingaMirjam Kretzschmar
Mar 15, 2008·Nature Reviews. Microbiology·Aras KadiogluPeter W Andrew
Mar 28, 2008·PLoS Medicine·Joël MossongW John Edmunds
Feb 24, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dang Duc AnhLuis Jodar
Jul 1, 2009·Pediatrics·Susan S HuangJonathan A Finkelstein
Jul 9, 2009·JAMA : the Journal of the American Medical Association·Elske J M van GilsElisabeth A M Sanders
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
May 15, 2010·Lancet·Robert E BlackUNKNOWN Child Health Epidemiology Reference Group of WHO and UNICEF
Apr 8, 2011·Emerging Infectious Diseases·Judith SpijkermanElisabeth A M Sanders
Oct 8, 2011·PLoS Medicine·Igor RudanUNKNOWN WHO/CHNRI Expert Group on Childhood Pneumonia
Mar 21, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Orin S LevineJ Anthony G Scott
Apr 19, 2012·Bulletin of the World Health Organization·Adam L CohenMargaret Watkins
May 25, 2012·Vaccine·UNKNOWN WHO Publication
Dec 18, 2013·The Pediatric Infectious Disease Journal·Cynthia G WhitneyKatherine L O'Brien
Jun 16, 2015·The Pediatric Infectious Disease Journal·Olivier Le Polain De WarouxW John Edmunds

❮ Previous
Next ❯

Citations

Nov 21, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ellen Signe Filtenborg TvedskovMichaela Tinggaard

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.